Literature DB >> 27822595

Is protein C zymogen really ineffective for ALL cases of sepsis including septic DIC?

Toshiaki Iba1, Jecko Thachil2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27822595     DOI： 10.1007/s00134-016-4615-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

3.  Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.

Authors:  Federico Pappalardo; Martina Crivellari; Ambra L Di Prima; Nataliya Agracheva; Malgorzata Celinska-Spodar; Rosalba Lembo; Daiana Taddeo; Giovanni Landoni; Alberto Zangrillo
Journal:  Intensive Care Med       Date:  2016-06-25       Impact factor: 17.440

Review 4.  Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.

Authors:  Y Umemura; K Yamakawa; H Ogura; H Yuhara; S Fujimi
Journal:  J Thromb Haemost       Date:  2016-02-01       Impact factor: 5.824

5.  Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.

Authors:  Kazuma Yamakawa; Yutaka Umemura; Mineji Hayakawa; Daisuke Kudo; Masamitsu Sanui; Hiroki Takahashi; Yoshiaki Yoshikawa; Toshimitsu Hamasaki; Satoshi Fujimi
Journal:  Crit Care       Date:  2016-07-29       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.